Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?
- PMID: 38201579
- PMCID: PMC10778544
- DOI: 10.3390/cancers16010152
Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?
Abstract
Despite recent() improvements in diagnostic ability() and treatment() strategies for patients() with neoplastic disease(), gastrointestinal (GI) cancers(), such() as colorectal, gastric, pancreatic, and oesophageal cancers(), are still common() malignancies and the leading() cause() of cancer() deaths worldwide(), with a high frequency of recurrence and metastasis as well as poor patient() prognosis. There is a link() between the secretion of proteolytic enzymes that degrade the extracellular matrix and the pathogenesis of GI tumours. Recent() findings have focused() on the potential() significance() of selected claudins (CLDNs) in the pathogenesis and prognosis of GI cancers(). Tight junctions (TJs) have been proven to play an important role() in maintaining cell() polarity and permeability. A number of authors have recently() revealed that TJ proteins, particularly() selected CLDNs, are related() to inflammation and the development() of various tumours, including GI malignancies. This review() presents general() characteristics and the involvement() of selected CLDNs in the progression() of GI malignancies, with a focus() on the potential() application() of these proteins in the diagnosis() and prognosis of colorectal cancer() (CRC), gastric cancer() (GC), pancreatic cancer() (PC), and oesophageal cancer() (EC). Our review() indicates that selected CLDNs, particularly() CLDN1, 2, 4, 7, and 18, play a significant() role() in the development() of GI tumours and in patient() prognosis. Furthermore, selected CLDNs may be of value() in the design() of therapeutic() strategies for the treatment() of recurrent tumours.
Keywords: biomarker; claudins; gastrointestinal tumours.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
A Disintegrin and Metalloproteinase (ADAM) Family-Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?Cancers (Basel). 2022 May 6;14(9):2307. doi: 10.3390/cancers14092307. Cancers (Basel). 2022. PMID: 35565436 Free PMC article. Review.
-
Claudins and Gastric Cancer: An Overview.Cancers (Basel). 2022 Jan 7;14(2):290. doi: 10.3390/cancers14020290. Cancers (Basel). 2022. PMID: 35053454 Free PMC article. Review.
-
The Role of Selected Serpins in Gastrointestinal (GI) Malignancies.J Clin Med. 2022 Oct 21;11(20):6225. doi: 10.3390/jcm11206225. J Clin Med. 2022. PMID: 36294546 Free PMC article. Review.
-
[Study of claudins and prognostic factors in some gastrointestinal diseases].Magy Onkol. 2009 Dec;53(4):377-83. doi: 10.1556/MOnkol.53.2009.4.7. Magy Onkol. 2009. PMID: 20071310 Hungarian.
-
Cross-over endocytosis of claudins is mediated by interactions via their extracellular loops.PLoS One. 2017 Aug 15;12(8):e0182106. doi: 10.1371/journal.pone.0182106. eCollection 2017. PLoS One. 2017. PMID: 28813441 Free PMC article.
Cited by
-
Intestinal Dysbiosis, Tight Junction Proteins, and Inflammation in Rheumatoid Arthritis Patients: A Cross-Sectional Study.Int J Mol Sci. 2024 Aug 8;25(16):8649. doi: 10.3390/ijms25168649. Int J Mol Sci. 2024. PMID: 39201334 Free PMC article.
References
-
- Hennessy B.T., Gonzalez-Angulo A.M., Stemke-Hale K., Gilcrease M.Z., Krishnamurthy S., Lee J.S., Fridlyand J., Sahin A., Agarwal R., Joy C., et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 2009;69:4116–4124. doi: 10.1158/0008-5472.CAN-08-3441. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous